Conviction
$ Value
$27K
Shares
5,000
Price
$5
Filed
May 15
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Zaderej Karen L.
Title
—
CIK
0001530968
Roles
Transaction Details
Transaction Date
2025-05-15
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
26,500
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.41 to $5.42. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.45 to $5.48. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Zaderej Karen L.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | EYPT | A | $0 |
| 2025-07-11 | EYPT | M | $0 |
| 2025-07-11 | EYPT | M | $0 |
| 2025-05-19 | EYPT | ▲ | $30K ★ |
| 2025-05-16 | EYPT | ▲ | $29K |
| 2025-05-15 | EYPT | ▲ | $27K |
| 2025-05-14 | EYPT | ▲ | $27K |
Other Insiders at EYPT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Duker Jay S.
President and CEO
|
— | — | 2026-03-23 |
|
Ribeiro Ramiro
Chief Medical Officer
|
— | $73K | 2026-04-17 |